INTECH Investment Management’s Solid Biosciences SLDB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-16,302
Closed -$163K – 1957
2026
Q2
$163K Sell
16,302
-276
-2% -$2.09K ﹤0.01% 1843
2026
Q1
$119K Sell
16,578
-17,907
-52% -$115K ﹤0.01% 1865
2025
Q4
$194K Buy
34,485
+4,539
+15% +$24.6K ﹤0.01% 2000
2025
Q3
$185K Sell
29,946
-6,416
-18% -$37.5K ﹤0.01% 2100
2025
Q2
$177K Buy
36,362
+18,619
+105% +$65.8K ﹤0.01% 2131
2025
Q1
$65.6K Buy
17,743
+6,878
+63% +$29.4K ﹤0.01% 2396
2024
Q4
$43.5K Buy
+10,865
New +$59.7K ﹤0.01% 2342

Other funds holding SLDB

INTECH Investment Management's SLDB Position: Q3 2026 in Review

INTECH Investment Management sold out of Solid Biosciences (SLDB) in Q3 2026, closing a stake of 16,302 shares — an estimated $163K sold.

INTECH Investment Management first reported a position in SLDB in Q4 2024 and held it in 7 quarters. The position peaked at $194K in Q4 2025. 158 funds tracked by Wall St. Rank hold SLDB as of Q3 2026.

  • INTECH Investment Management reported no remaining Solid Biosciences position as of Q3 2026 after selling out during the quarter.
  • INTECH Investment Management sold 16,302 Solid Biosciences shares in Q3 2026, an estimated $163K.
  • INTECH Investment Management first reported a position in Solid Biosciences in Q4 2024 and held it in 7 quarters.
  • INTECH Investment Management's Solid Biosciences position peaked at $194K in Q4 2025.
  • 158 funds tracked by Wall St. Rank held Solid Biosciences as of Q3 2026.

Based on INTECH Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.